HB 348 Illinois House · 102nd Regular Session

CONTROLLED SUBSTANCE-PRESCRIBE

Summary
Amends the Illinois Controlled Substances Act. Provides that a prescriber shall offer a prescription for naloxone hydrochloride, or another similar drug approved by the Food and Drug Administration, under specified circumstances. Provides for educational information to be provided concerning overdose prevention and the use of naloxone hydrochloride. Provides that a prescriber who does not comply with specified requirements shall be subject to administrative sanctions under the appropriate licensing board. Specifies that the provisions do not create a private right of action against a prescriber, and do not limit a prescriber's liability for the negligent failure to diagnose or treat a patient. Provides that these provisions do apply to a patient receiving hospice care in accordance with the Hospice Program Licensing Act. Contains a purpose provision. Effective immediately.
Bill status failed 1 of 4 stages cleared
Introduction
Jan 2021
Committee Review
Floor Vote
Governor
Introduced Jan 28, 2021 Last action Jan 10, 2023
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
16
Key actions
1
Committee
7
Amendments
1
Mar 27, 2021
Committee
House Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee
lower
Mar 27, 2021
Committee
Rule 19(a) / Re-referred to Rules Committee
lower
Mar 18, 2021
Lower · Passed
House Committee Amendment No. 1 Rules Refers to Mental Health & Addiction Committee
lower
Mar 16, 2021
Committee
House Committee Amendment No. 1 Referred to Rules Committee
lower
Mar 16, 2021
Introduced
House Committee Amendment No. 1 Filed with Clerk by Rep. Deb Conroy
lower
Mar 9, 2021
Committee
Re-assigned to Mental Health & Addiction Committee
lower
Mar 2, 2021
Committee
Assigned to Health Care Licenses Committee
lower
Jan 29, 2021
Committee
Referred to Rules Committee
lower
1 primary · 5 co-sponsors

Sponsors